After-Hours Stock Movers 03/11: (CFRX) (NVAX) (FNKO) Higher; (MRKR) (POSH) (ULTA) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Cyclacel Pharma (CYCC) Prices 1.807M Share Common Offering at $7/Sh
March 12, 2021 8:31 AM ESTCyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the pricing of an underwritten public offering of 1,807,143 shares of its common stock, offered at a price of $7.00 to the public. Additionally, the Company has granted the underwriters a 30-day option to purchase up to an additional 271,071 shares of common stock at the public... More
Marker Therapeutics (MRKR) Prices 28.572M Share Common Offering at $1.75/Sh
March 12, 2021 8:02 AM ESTMarker Therapeutics, Inc. (NASDAQ: MRKR) today announced the pricing of an underwritten public offering of 28,572,000 shares of its common stock at a public offering price of $1.75 per share. The gross proceeds to Marker from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $50.0... More
Funko (FNKO) PT Raised to $17 at DA Davidson
March 12, 2021 6:58 AM ESTDA Davidson analyst Linda Bolton Weiser raised the price target on Funko (NASDAQ: FNKO) to $17.00 (from $7.00) while maintaining a Neutral rating.
The analyst commented, "FNKO reported 4Q20 sales and EBITDA upside surprises, with sales returning to growth (+6%), and the stock was up ~10% after hours.... More
